Skip to main content
See every side of every news story
Published • loading... • Updated

Ocular Therapeutix (NASDAQ:OCUL) Earns Buy Rating from HC Wainwright

Summary by MarketBeat
HC Wainwright reaffirmed a "buy" rating and set a $28.00 target price on shares of Ocular Therapeutix in a report on Tuesday.

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Tuesday, November 17, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal